Crescent Biopharma, Inc. (CBIO)

Crescent Biopharma Statistics

Total Valuation

CBIO has a market cap or net worth of $248.23 million.

Market Cap	248.23M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Saturday, August 23, 2025, after market close.

Earnings Date	Aug 23, 2025
Ex-Dividend Date	n/a

Share Statistics

CBIO has 14.95 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	14.95M
Shares Outstanding	14.95M
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	5.10%
Owned by Institutions (%)	n/a
Float	8.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	50,434

Short Selling Information

The latest short interest is 1.71 million, so 11.44% of the outstanding shares have been sold short.

Short Interest	1.71M
Short Previous Month	1.68M
Short % of Shares Out	11.44%
Short % of Float	19.12%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	-25.70M
FCF Per Share	-$1.72

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	-0.19%
Earnings Yield	n/a
FCF Yield	-10.07%

Analyst Forecast

The average price target for CBIO is $25.00, which is 50.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	50.60%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a